NCT07576270 Effect of Resisted Deep Breathing and Myofascial Release in Postmastectomy
| NCT ID | NCT07576270 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Post Mastectomy Lymphedema |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 48 participants in total. It began in 2025-10-01 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to determine the combined effect of resisted deep breathing and Myofascial release on pain, respiratory efficiency, chest mobility and lymph edema in Postmastectomy.
Eligibility Criteria
Inclusion Criteria: * Radiation therapy and chemotherapy was finished at least three months * 6 months after mastectomy for breast cancer being diagnosed without lymphedema or with stage 1 lymphedema * Complete unilateral Mastectomy * pain and having one or more of the following symptoms: heaviness, numbness, oppression, stiffness, alterations in the function, or mobility of the limited shoulder range of motion. Exclusion Criteria: * Presence of shoulder pathologies for which surgical indications exist * Musculoskeletal injury in adjacent areas (shoulder or neck etc.) * bilateral surgery for the treatment of breast cancer * Bilateral lymphadenectomy * Open wounds on upper limbs * Circulatory disorders * History of shoulder surgery for reasons other than breast cancer.
Contact & Investigator
hina gul, PhD*
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07576270 clinical trial?
This trial is open to female participants only, aged 45 Years or older, up to 64 Years, studying Post Mastectomy Lymphedema. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07576270 currently recruiting?
Yes, NCT07576270 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07576270 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07576270 clinical trial?
NCT07576270 is sponsored by Riphah International University. The principal investigator is hina gul, PhD* at Riphah International University. The trial plans to enroll 48 participants.